Paolo Mignatti

10.6k citations
98 papers · 8.9k indexed · 4 hit papers · h-index 40
Topics
Protease and Inhibitor Mechanisms (48 papers)Blood Coagulation and Thrombosis Mechanisms (23 papers)Angiogenesis and VEGF in Cancer (21 papers)
Partner nations
United StatesItalyCanada

In The Last Decade

Paolo Mignatti

96 papers receiving 8.6k citations

Hit Papers

Biology and biochemistry of proteinases in tumor invasion198620261999201219931998198620182505007501000

Peers

Paolo Mignatti
Comparison fields: 5 of 128
  • Molecular Biology 4.5k
  • Cancer Research 3.7k
  • Oncology 2.1k
  • Hematology 1.4k
  • Immunology and Allergy 1.4k
Replace Olli Saksela with:
Olli Saksela Finland
Yuen Shing United States
Suneel Apte United States
Thiennu H. Vu United States
Kaoru Miyazaki Japan
Reuven Reich Israel
Noël Bouck United States
Vera Knäuper United Kingdom
John J. Reynolds United Kingdom
Elena I. Deryugina United States
Paolo Mignatti relative to Olli Saksela Finland Olli Saksela's profile →
Citations per field
00.5×2.7×
Olli Saksela · 1×
Citations per year

Countries citing papers authored by Paolo Mignatti

Since Specialization
Citations

This map shows the geographic impact of Paolo Mignatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Mignatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Mignatti more than expected).

Fields of papers citing papers by Paolo Mignatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Mignatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Mignatti. The network helps show where Paolo Mignatti may publish in the future.

Co-authorship network of co-authors of Paolo Mignatti

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Mignatti. A scholar is included among the top collaborators of Paolo Mignatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Mignatti. Paolo Mignatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 2
3 47
4 60
5 55
6 23
7 58
8 18
9 9
10 56
11 35
12 37
13 283
14
Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.
99
15 151
16 26
17 35
18 33
19 124
20 17

About Paolo Mignatti

Paolo Mignatti is a scholar working on Cancer Research, Hematology and Immunology and Allergy, having authored 98 papers that have together received 8.9k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (48 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Angiogenesis and VEGF in Cancer (21 papers). The work is most often cited by research in Cancer Research (3.7k citations), Immunology and Allergy (1.4k citations) and Hematology (1.4k citations). Paolo Mignatti has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Daniel B. Rifkin, E. Robbins, Giuseppe Pintucci, Aubrey C. Galloway, Takashi Morimoto, Graziano Seghezzi, Sylvia Adams, Arthur Winer, Sara Monea and D B Rifkin. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026